• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374

Professional Introduction to Compound with CAS No. 1408076-24-3 and Product Name: Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate

The compound with the CAS number 1408076-24-3 and the product name Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate represents a significant advancement in the field of pharmaceutical chemistry. This compound, characterized by its unique structural and functional properties, has garnered considerable attention in recent years due to its potential applications in drug development and medicinal chemistry. The molecular structure of this compound, featuring a tert-butyl group and a cis-N-(3-amino-3-methyl-cyclobutyl)carbamate moiety, contributes to its distinctive chemical behavior and reactivity, making it a valuable candidate for further exploration.

In the realm of pharmaceutical research, the significance of Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate lies in its ability to serve as a versatile intermediate in the synthesis of more complex molecules. The presence of the tert-butyl group provides steric hindrance, which can be strategically employed to modulate the pharmacokinetic properties of derived compounds. Meanwhile, the cis-N-(3-amino-3-methyl-cyclobutyl)carbamate moiety introduces a rigid cyclic structure that can enhance binding affinity to biological targets. These features make this compound particularly interesting for designing novel therapeutic agents.

Recent studies have highlighted the potential of this compound in the development of central nervous system (CNS) therapeutics. The structural framework of Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate exhibits similarities to known bioactive molecules that interact with neurotransmitter receptors. This has prompted researchers to investigate its interactions with enzymes and receptors involved in neurodegenerative diseases, such as Alzheimer's and Parkinson's. Preliminary findings suggest that derivatives of this compound may exhibit promising pharmacological effects, including neuroprotective and anti-inflammatory properties.

The synthesis of Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate involves sophisticated organic reactions that showcase the ingenuity of modern synthetic chemistry. The process typically begins with the formation of a cyclobutane ring, followed by functionalization with an amino group and subsequent carbamate formation. The introduction of the tert-butyl group at an appropriate position ensures optimal steric orientation, which is crucial for biological activity. Advanced techniques such as catalytic hydrogenation and protecting group strategies are employed to achieve high yields and purity, underscoring the compound's synthetic elegance.

From a medicinal chemistry perspective, the versatility of Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate lies in its ability to be modified at multiple sites. Researchers can alter the substituents on the cyclobutane ring or introduce additional functional groups to fine-tune its pharmacological profile. This flexibility has led to several derivative compounds being explored for their potential therapeutic benefits. For instance, modifications aimed at enhancing lipophilicity or metabolic stability have shown encouraging results in preclinical studies, paving the way for further development.

The role of computational chemistry in understanding the behavior of Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate cannot be overstated. Molecular modeling techniques have been instrumental in predicting how this compound interacts with biological targets at the atomic level. By simulating these interactions, researchers can gain insights into binding affinities, metabolic pathways, and potential side effects before conducting expensive wet-lab experiments. This approach not only accelerates drug discovery but also reduces costs associated with trial-and-error methodologies.

Future directions in the study of Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate include exploring its role in antimicrobial therapy. The unique structural features of this compound may confer activity against resistant bacterial strains by interfering with essential enzymatic processes. Additionally, investigating its interactions with other biological systems, such as immune modulators or anti-inflammatory agents, could open new avenues for therapeutic applications. Collaborative efforts between academic institutions and pharmaceutical companies are essential to translate these findings into tangible medical breakthroughs.

The environmental impact of synthesizing and utilizing Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate is another critical consideration. Modern synthetic protocols emphasize green chemistry principles to minimize waste and reduce hazardous byproducts. Techniques such as solvent recovery systems and catalytic processes that promote high selectivity are being adopted to ensure sustainable production practices. These efforts align with global initiatives aimed at promoting responsible chemical manufacturing while maintaining high standards of efficacy and safety.

In conclusion, Tert-butyl cis-N-(3-amino-3-methyl-cyclobutyl)carbamate (CAS No. 1408076-24-3) represents a compelling example of how structural innovation can drive advancements in pharmaceutical science. Its unique combination of steric hindrance from the tert-butyl group and rigid cyclic architecture from the cis-N-(3-amino-3-methyl-cyclobutul)carbamate moiety positions it as a versatile scaffold for drug development. With ongoing research uncovering new therapeutic potentials and sustainable synthetic methods gaining traction, this compound is poised to play a significant role in shaping future medical treatments.

• 372963-43-4(tert-Butyl N-3-Aminoadamant-1-ylcarbamate)
• 1461706-82-0(tert-butyl N-(5-aminonorpinan-1-yl)carbamate;hydrochloride)
• 1050890-47-5(tert-butyl N-(4-amino-1-bicyclo[2.1.1]hexanyl)carbamate)
• 886362-50-1(tert-butyl N-1-(2-aminoethyl)cyclohexylcarbamate)
• 1408074-61-2(tert-butyl trans-N-(3-amino-1-methyl-cyclobutyl)carbamate)
• 1638767-25-5(tert-butyl N-(3-amino-1-bicyclo[1.1.1]pentanyl)carbamate)
• 1408075-91-1(tert-butyl trans-N-(3-amino-3-methyl-cyclobutyl)carbamate)
• 1895535-27-9(tert-Butyl N-[1-(2-aminoethyl)cyclobutyl]carbamate)
• 1049607-15-9(tert-butyl N-(5-aminonorpinan-1-yl)carbamate)
• 1408076-04-9(tert-butyl cis-N-(3-amino-1-methyl-cyclobutyl)carbamate)